Memo Therapeutics Ag Closes Series B Financing At Chf37 Million Following Oversubscribed Chf23 Million Extension
Round Type
Series B
SchlierenBiotechnologyHealth CareScience And EngineeringDescription
Memo Therapeutics AG (“MTx”), an innovator in the field of antibody discovery and development, announced today the close of an oversubscribed Series B financing round led by Swisscanto Invest at CHF37 million after securing an additional CHF23 million from a combination of strategic and financial investors, including Adjuvant Capital, Fresenius Medical Care Ventures, GF Group, Verve Ventures, Vesalius Biocapital and Zürcher Kantonalbank.
Quick answer
Memo Therapeutics AG raised an undisclosed amount in a Series B round, dated February 16, 2022. Memo Therapeutics AG is based in Schlieren, Zurich, Switzerland.
- How much did Memo Therapeutics AG raise?
- Memo Therapeutics AG raised an undisclosed amount in a Series B round on February 16, 2022.
- What does Memo Therapeutics AG do?
- Memo Therapeutics AG is an innovator in the field of antibody discovery and immune repertoire analysis.
- Where is Memo Therapeutics AG based and how big is it?
- Memo Therapeutics AG is based in Schlieren, Zurich, Switzerland.
- Who are the decision-makers at Memo Therapeutics AG?
- Fundz holds 1 contact at Memo Therapeutics AG. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Science And Engineering and Biotechnology around the same time
Companies in the same sectors as Memo Therapeutics AG that raised within 45 days of this round, from Fundz verified event records.
- 2seventy bio raised $170M on March 31, 2022.
- Zephyr AI, Inc. raised $19M (Seed) on March 30, 2022.
- Geneos Therapeutics raised $17M on March 28, 2022.
- Geneos Therapeutics raised $17M (Series A) on March 24, 2022.
- Nucleai raised $33M (Series B) on March 22, 2022.
- Theriva Biologics raised $1.5M (Seed) on March 21, 2022.
Who to call at Memo Therapeutics AG, and when
A new round usually means Memo Therapeutics AG is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Memo Therapeutics AG raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Memo Therapeutics AG, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Memo Therapeutics AG. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Memo Therapeutics AG raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansMemo Therapeutics AG raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.